Table 1 Receipt of lipid-lowering pharmacotherapy among Atherosclerosis Risk in Community (ARIC) surveillance patients (1999–2002): results from regression models for selected variables
Variable | Prevalence ratio | 95% CI |
|---|---|---|
Model 1 | ||
nINC | ||
Low nINC | 0.89 | 0.79, 1.01 |
Medium nINC | 0.98 | 0.91, 1.07 |
High nINC | 1.00 | ref |
Gender | ||
Female | 0.91 | 0.84, 0.98 |
Male | 1.00 | ref |
Race | ||
Black | 0.86 | 0.76, 0.97 |
White | 1.00 | ref |
Model 2 | ||
nINC | ||
Low nINC | 0.91 | 0.81, 1.03 |
Medium nINC | 1.00 | 0.92,1.08 |
High nINC | 1.00 | ref |
Gender | ||
Female | 0.92 | 0.85, 1.00 |
Male | 1.00 | ref |
Race | ||
Black | 0.90 | 0.79, 1.02 |
White | 1.00 | ref |
Hospital type | ||
Teaching | 0.87 | 0.79, 0.96 |
Non-teaching | 1.00 | ref |
Medical history | ||
Hypertension | 0.99 | 0.92, 1.06 |
Diabetes | 1.05 | 0.97, 1.14 |
Heart failure | 0.72 | 0.65, 0.79 |